Literature DB >> 17030785

Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.

Paul H Gordon, Ying Kuen Cheung.   

Abstract

Mesh：

Year:  2006        PMID： 17030785     DOI： 10.1212/01.wnl.0000243812.25517.87

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  Progression in ALS is not linear but is curvilinear.

Authors:  Paul H Gordon; Bin Cheng; Francois Salachas; Pierre-Francois Pradat; Gaelle Bruneteau; Philippe Corcia; Lucette Lacomblez; Vincent Meininger
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

Review 2.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Michael E Bozik; Evan W Ingersoll; Robert Miller; Hiroshi Mitsumoto; Jeremy Shefner; Dan H Moore; David Schoenfeld; James L Mather; Donald Archibald; Mary Sullivan; Craig Amburgey; Juliet Moritz; Valentin K Gribkoff
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

4.  Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.

Authors:  Juan F Vázquez-Costa; Inmaculada Máñez; Ana Alabajos; Maricruz Guevara Salazar; Cristina Roda; Teresa Sevilla
Journal:  J Neurol       Date:  2016-07-06       Impact factor: 4.849

5.  Resting state functional brain networks associated with emotion processing in frontotemporal lobar degeneration.

Authors:  Elisa Canu; Davide Calderaro; Veronica Castelnovo; Silvia Basaia; Maria Antonietta Magno; Nilo Riva; Giuseppe Magnani; Francesca Caso; Paola Caroppo; Sara Prioni; Cristina Villa; Debora Pain; Gabriele Mora; Lucio Tremolizzo; Ildebrando Appollonio; Barbara Poletti; Vincenzo Silani; Massimo Filippi; Federica Agosta
Journal:  Mol Psychiatry       Date:  2022-05-20       Impact factor: 15.992

6.  Speech Movement Measures as Markers of Bulbar Disease in Amyotrophic Lateral Sclerosis.

Authors:  Sanjana Shellikeri; Jordan R Green; Madhura Kulkarni; Panying Rong; Rosemary Martino; Lorne Zinman; Yana Yunusova
Journal:  J Speech Lang Hear Res       Date:  2016-10-01       Impact factor: 2.297

7.  A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

Authors:  Paul H Gordon; Ying-Kuen Cheung; Bruce Levin; Howard Andrews; Carolyn Doorish; Robert B Macarthur; Jacqueline Montes; Kate Bednarz; Julaine Florence; Julie Rowin; Kevin Boylan; Tahseen Mozaffar; Rup Tandan; Hiroshi Mitsumoto; Elizabeth A Kelvin; John Chapin; Richard Bedlack; Michael Rivner; Leo F McCluskey; Alan Pestronk; Michael Graves; Eric J Sorenson; Richard J Barohn; Jerry M Belsh; Jau-Shin Lou; Todd Levine; David Saperstein; Robert G Miller; Stephen N Scelsa
Journal:  Amyotroph Lateral Scler       Date:  2008-08

8.  Predicting functional decline and survival in amyotrophic lateral sclerosis.

Authors:  Mei-Lyn Ong; Pei Fang Tan; Joanna D Holbrook
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

9.  A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Authors:  Leila Bond; Paulamy Ganguly; Nishad Khamankar; Nolan Mallet; Gloria Bowen; Braden Green; Cassie S Mitchell
Journal:  Brain Sci       Date:  2019-09-04

10.  Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.

Authors:  Jiayu Fu; Ji He; Wei Zhao; Chuan Ren; Ping Liu; Lu Chen; Dan Li; Lu Tang; Lequn Zhou; Yixuan Zhang; Xinran Ma; Gaoqi Zhang; Nan Li; Dongsheng Fan
Journal:  J Neurol       Date:  2021-07-18       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.